Abstract
For recent years, the labeling and application of Somatostatin and Its Analogues have been becoming more and more important in the both diagnosis and treatment of a variety of tumors, especially the neuroendocrine tumors. This paper's goals are to deal with the chemical aspects of the radiolabeling of somatostatin and its analogues. It reviews the selected radionuclides and bifunctional chelating agents may be used in the labeling of Somatostatin and its analogues with metal radionuclides. The prospects of application of the Labelled Somatostatin and its analogues are comparatively assessed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Radioanalytical and Nuclear Chemistry Articles
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
